Vivos Therapeutics, Inc. (VVOS)
0.0569
-0.02
(-25.13%)
USD |
NASDAQ |
Nov 19, 16:00
0.0567
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Total Liabilities (Quarterly) : 20.69M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.69M |
| June 30, 2026 | 28.13M |
| March 31, 2026 | 26.31M |
| December 31, 2025 | 26.70M |
| September 30, 2025 | 23.11M |
| June 30, 2025 | 21.45M |
| March 31, 2025 | 6.875M |
| December 31, 2024 | 7.33M |
| September 30, 2024 | 7.682M |
| June 30, 2024 | 9.495M |
| March 31, 2024 | 11.22M |
| December 31, 2023 | 10.32M |
| September 30, 2023 | 10.27M |
| June 30, 2023 | 11.64M |
| Date | Value |
|---|---|
| March 31, 2023 | 10.11M |
| December 31, 2022 | 8.919M |
| September 30, 2022 | 8.545M |
| June 30, 2022 | 9.536M |
| March 31, 2022 | 8.517M |
| December 31, 2021 | 8.15M |
| September 30, 2021 | 8.555M |
| June 30, 2021 | 9.673M |
| March 31, 2021 | 7.614M |
| December 31, 2020 | 8.410M |
| September 30, 2020 | 8.494M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 9.178M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Hinge Health, Inc. | 574.66M |
| Exlites Holdings International, Inc. | 0.1078M |
| Xcelerate, Inc. | 2.331M |
| Abbott Laboratories | 56.62B |
| AngioDynamics, Inc. | 77.97M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.86M |
| Shareholders Equity (Quarterly) | 2.36M |
| Debt to Equity Ratio | 2.538 |
| Current Ratio | 0.217 |
| Net Debt Paydown Yield | 22.36% |